Titan Biotech - target for 215There is good indication of reversal and trend change from 30th March onwards. Two dates are mentioned in the chart.
Target 215 ++ (20% ++ profit from here)
Follow me for more ideas like this.
30.00INR
248.44 MINR
1.44 BINR
About TITAN BIOTECH LTD.
Sector
Industry
Headquarters
New Delhi
Website
Employees (FY)
396
Founded
1992
ISIN
INE150C01011
FIGI
BBG000BNLJY4
Titan Biotech Ltd. is a holding company, which engages in manufacturing and exporting of biological products used in the field of Pharmaceutical, Nutraceutical, Food & Beverages, Biotechnology & Fermentation, Cosmetic, Veterinary & Animal Feed, Agriculture Industries, Microbiology Culture Media & Plant Tissue Culture Media. The company was founded on February 18, 1992 and is headquartered in New Delhi, India.
TITAN BIOTECH, PROMOTERS ARE BUYINGFOLLOW THE DETAILS ON CHART, PROMOTERS ARE CONTINIOUSLY BUYING STOCK. ONW SHOULD BUY AND HOLD FOR A 3 TO 4 MONTH PERIOD
Titan Biotech above Rs. 300++ My target for this beautiful and undervalued stock Rs. 300++ in next few months. Once Nifty corrects, this is the stock (monthly chart is good). And strength vs Nifty 50 is good too. If this sustains we can easily see the Elliott wave 3 ending at about Rs. 322.
What are we talking about?
Tar
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TITANBIO is 496.35 INR — it has decreased by 0.98% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange TITAN BIOTECH LTD. stocks are traded under the ticker TITANBIO.
TITANBIO stock is 2.62% volatile and has beta coefficient of 0.05. Check out the list of the most volatile stocks — is TITAN BIOTECH LTD. there?
Yes, you can track TITAN BIOTECH LTD. financials in yearly and quarterly reports right on TradingView.
TITANBIO stock has fallen by 3.90% compared to the previous week, the month change is a 1.40% fall, over the last year TITAN BIOTECH LTD. has showed a 105.10% increase.
TITANBIO net income for the last quarter is 71.75 M INR, while the quarter before that showed 65.21 M INR of net income which accounts for 10.02% change. Track more TITAN BIOTECH LTD. financial stats to get the full picture.
Today TITAN BIOTECH LTD. has the market capitalization of 4.14 B, it has decreased by 3.86% over the last week.
Yes, TITANBIO dividends are paid annually. The last dividend per share was 1.80 INR. As of today, Dividend Yield (TTM)% is 0.36%. Tracking TITAN BIOTECH LTD. dividends might help you take more informed decisions.
TITAN BIOTECH LTD. dividend yield was 0.91% in 2022, and payout ratio reached 5.99%. The year before the numbers were 0.57% and 5.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, TITANBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TITAN BIOTECH LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 396.00 employees. See our rating of the largest employees — is TITAN BIOTECH LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TITAN BIOTECH LTD. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TITAN BIOTECH LTD. stock shows the buy signal. See more of TITAN BIOTECH LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TITAN BIOTECH LTD. EBITDA is 340.35 M INR, and current EBITDA margin is 20.85%. See more stats in TITAN BIOTECH LTD. financial statements.